Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Inhibiting eicosanoid degradation exerts antifibrotic effects in a pulmonary fibrosis mouse model and human tissue.

Bärnthaler T, Theiler A, Zabini D, Trautmann S, Stacher-Priehse E, Lanz I, Klepetko W, Sinn K, Flick H, Scheidl S, Thomas D, Olschewski H, Kwapiszewska G, Schuligoi R, Heinemann A.

J Allergy Clin Immunol. 2020 Mar;145(3):818-833.e11. doi: 10.1016/j.jaci.2019.11.032. Epub 2019 Dec 5.

2.

Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension.

Papp R, Nagaraj C, Zabini D, Nagy BM, Lengyel M, Skofic Maurer D, Sharma N, Egemnazarov B, Kovacs G, Kwapiszewska G, Marsh LM, Hrzenjak A, Höfler G, Didiasova M, Wygrecka M, Sievers LK, Szucs P, Enyedi P, Ghanim B, Klepetko W, Olschewski H, Olschewski A.

Eur Respir J. 2019 Jun 5;53(6). pii: 1800965. doi: 10.1183/13993003.00965-2018. Print 2019 Jun.

PMID:
31023847
3.

Rho-Kinase Inhibition Ameliorates Dasatinib-Induced Endothelial Dysfunction and Pulmonary Hypertension.

Fazakas C, Nagaraj C, Zabini D, Végh AG, Marsh LM, Wilhelm I, Krizbai IA, Olschewski H, Olschewski A, Bálint Z.

Front Physiol. 2018 May 15;9:537. doi: 10.3389/fphys.2018.00537. eCollection 2018.

4.

The Role of the Human Immune System in Chronic Hypoxic Pulmonary Hypertension.

Hu Y, Zabini D, Gu W, Goldenberg NM, Breitling S, Kabir G, Connelly KA, Kuebler WM.

Am J Respir Crit Care Med. 2018 Aug 15;198(4):528-531. doi: 10.1164/rccm.201711-2175LE. No abstract available.

PMID:
29630848
5.

Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF Disinhibition.

Zabini D, Granton E, Hu Y, Miranda MZ, Weichelt U, Breuils Bonnet S, Bonnet S, Morrell NW, Connelly KA, Provencher S, Ghanim B, Klepetko W, Olschewski A, Kapus A, Kuebler WM.

Am J Respir Crit Care Med. 2018 Jan 15;197(2):244-260. doi: 10.1164/rccm.201702-0386OC. Erratum in: Am J Respir Crit Care Med. 2019 Apr 1;199(7):932.

PMID:
29095649
6.

Adverse Heart-Lung Interactions in Ventilator-induced Lung Injury.

Katira BH, Giesinger RE, Engelberts D, Zabini D, Kornecki A, Otulakowski G, Yoshida T, Kuebler WM, McNamara PJ, Connelly KA, Kavanagh BP.

Am J Respir Crit Care Med. 2017 Dec 1;196(11):1411-1421. doi: 10.1164/rccm.201611-2268OC.

PMID:
28795839
7.

The mast cell-B cell axis in lung vascular remodeling and pulmonary hypertension.

Breitling S, Hui Z, Zabini D, Hu Y, Hoffmann J, Goldenberg NM, Tabuchi A, Buelow R, Dos Santos C, Kuebler WM.

Am J Physiol Lung Cell Mol Physiol. 2017 May 1;312(5):L710-L721. doi: 10.1152/ajplung.00311.2016. Epub 2017 Feb 24.

8.

Animal models of sarcoidosis.

Hu Y, Yibrehu B, Zabini D, Kuebler WM.

Cell Tissue Res. 2017 Mar;367(3):651-661. doi: 10.1007/s00441-016-2526-3. Epub 2016 Nov 2. Review.

PMID:
27807704
9.

CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction.

Tabeling C, Yu H, Wang L, Ranke H, Goldenberg NM, Zabini D, Noe E, Krauszman A, Gutbier B, Yin J, Schaefer M, Arenz C, Hocke AC, Suttorp N, Proia RL, Witzenrath M, Kuebler WM.

Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):E1614-23. doi: 10.1073/pnas.1421190112. Epub 2015 Mar 17.

10.

High-mobility group box-1 induces vascular remodelling processes via c-Jun activation.

Zabini D, Crnkovic S, Xu H, Tscherner M, Ghanim B, Klepetko W, Olschewski A, Kwapiszewska G, Marsh LM.

J Cell Mol Med. 2015 May;19(5):1151-61. doi: 10.1111/jcmm.12519. Epub 2015 Feb 28.

11.

Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients.

Zabini D, Heinemann A, Foris V, Nagaraj C, Nierlich P, Bálint Z, Kwapiszewska G, Lang IM, Klepetko W, Olschewski H, Olschewski A.

Eur Respir J. 2014 Oct;44(4):951-62. doi: 10.1183/09031936.00145013. Epub 2014 Jul 17.

12.

Double-stranded RNA attenuates the barrier function of human pulmonary artery endothelial cells.

Bálint Z, Zabini D, Konya V, Nagaraj C, Végh AG, Váró G, Wilhelm I, Fazakas C, Krizbai IA, Heinemann A, Olschewski H, Olschewski A.

PLoS One. 2013 Jun 3;8(6):e63776. doi: 10.1371/journal.pone.0063776. Print 2014.

13.

Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction.

Zabini D, Nagaraj C, Stacher E, Lang IM, Nierlich P, Klepetko W, Heinemann A, Olschewski H, Bálint Z, Olschewski A.

PLoS One. 2012;7(8):e43793. doi: 10.1371/journal.pone.0043793. Epub 2012 Aug 20.

Supplemental Content

Loading ...
Support Center